Akèy › Kansè bronch
Etid klinik pou Kansè bronch ap rekrite nan Etazini
8 etid pou Kansè bronch ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY6 etid
- Houston, TX5 etid
- Boston, MA4 etid
- Pittsburgh, PA4 etid
- Columbus, OH4 etid
- Arlington, VA3 etid
- Tampa, FL3 etid
- Indianapolis, IN3 etid
- Memphis, TN3 etid
- Chicago, IL3 etid
- Durham, NC3 etid
- Minneapolis, MN3 etid
- Los Angeles, CA3 etid
- Cincinnati, OH3 etid
- Miami, FL3 etid
Pa eta
- Colorado3 etid
- Florid6 etid
- Illinois5 etid
- Indiana3 etid
- Kalifòni6 etid
- Kentucky3 etid
- Massachusetts4 etid
- Michigan5 etid
- Minnesota3 etid
- New York6 etid
- North Carolina3 etid
- Ohio6 etid
- Pennsylvania5 etid
- Tennessee4 etid
- Texas5 etid
- Virginia4 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07185997Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jun 26, 2026 · NCT04614103A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Jun 11, 2026 · NCT05361174A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 21, 2026 · NCT06623656Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 19, 2026 · NCT02984761Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.